天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro-

Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro- Struktur
1781804-97-4
CAS-Nr.
1781804-97-4
Englisch Name:
Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro-
Synonyma:
7'-bromo-2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-isoquinolin]-1'-one;7'-Bromo-2',3'-dihydrospiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one;Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro-;Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro-
CBNumber:
CB98358016
Summenformel:
C11H10BrNO
Molgewicht:
252.11
MOL-Datei:
1781804-97-4.mol

Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro- Eigenschaften

Siedepunkt:
474.0±45.0 °C(Predicted)
Dichte
1.65±0.1 g/cm3(Predicted)
pka
14.37±0.20(Predicted)

Sicherheit

Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro- Chemische Eigenschaften,Einsatz,Produktion Methoden

Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Bejing Famous Pharmaceutical Technology Co., Ltd. 13331045123
 1963319514@qq.com China 14223 58
Pharmalego 13472578225 18321033991
 marketing@pharmalego.com China 2961 58
Taizhou Zhongzhi Biotechnology Co., Ltd 13012344321
 3995296515@qq.com China 7996 58
  • Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro-
  • 7'-Bromo-2',3'-dihydrospiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one
  • 7'-bromo-2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-isoquinolin]-1'-one
  • Spiro[cyclopropane-1,4'(1'H)-isoquinolin]-1'-one, 7'-bromo-2',3'-dihydro-
  • 1781804-97-4
Copyright 2019 ? ChemicalBook. All rights reserved